These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

975 related items for PubMed ID: 18240255

  • 1. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.
    Jais X, Launay D, Yaici A, Le Pavec J, Tchérakian C, Sitbon O, Simonneau G, Humbert M.
    Arthritis Rheum; 2008 Feb; 58(2):521-31. PubMed ID: 18240255
    [Abstract] [Full Text] [Related]

  • 2. Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension.
    Sanchez O, Sitbon O, Jaïs X, Simonneau G, Humbert M.
    Chest; 2006 Jul; 130(1):182-9. PubMed ID: 16840400
    [Abstract] [Full Text] [Related]

  • 3. Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment.
    Tanaka E, Harigai M, Tanaka M, Kawaguchi Y, Hara M, Kamatani N.
    J Rheumatol; 2002 Feb; 29(2):282-7. PubMed ID: 11838845
    [Abstract] [Full Text] [Related]

  • 4. Predictors of Favorable Responses to Immunosuppressive Treatment in Pulmonary Arterial Hypertension Associated With Connective Tissue Disease.
    Yasuoka H, Shirai Y, Tamura Y, Takeuchi T, Kuwana M.
    Circ J; 2018 Jan 25; 82(2):546-554. PubMed ID: 28904255
    [Abstract] [Full Text] [Related]

  • 5. The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review.
    Kato M, Kataoka H, Odani T, Fujieda Y, Otomo K, Oku K, Horita T, Yasuda S, Atsumi T, Ohira H, Tsujino I, Nishimura M, Koike T.
    Lupus; 2011 Oct 25; 20(10):1047-56. PubMed ID: 21676917
    [Abstract] [Full Text] [Related]

  • 6. Treatment of Vasodilator-resistant Mixed Connective Tissue Disease-associated Pulmonary Arterial Hypertension with Glucocorticoid and Cyclophosphamide.
    Sugawara E, Kato M, Hisada R, Oku K, Bohgaki T, Horita T, Yasuda S, Atsumi T.
    Intern Med; 2017 Oct 25; 56(4):445-448. PubMed ID: 28202869
    [Abstract] [Full Text] [Related]

  • 7. [Pulmonary arterial hypertension in connective tissue disease].
    Cottin V.
    Rev Mal Respir; 2006 Sep 25; 23(4 Suppl):13S61-72. PubMed ID: 17057632
    [Abstract] [Full Text] [Related]

  • 8. Pulmonary arterial hypertension in systemic lupus erythematosus may benefit by addition of immunosuppression to vasodilator therapy: an observational study.
    Kommireddy S, Bhyravavajhala S, Kurimeti K, Chennareddy S, Kanchinadham S, Rajendra Vara Prasad I, Rajasekhar L.
    Rheumatology (Oxford); 2015 Sep 25; 54(9):1673-9. PubMed ID: 25929760
    [Abstract] [Full Text] [Related]

  • 9. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.
    Sitbon O, Humbert M, Jaïs X, Ioos V, Hamid AM, Provencher S, Garcia G, Parent F, Hervé P, Simonneau G.
    Circulation; 2005 Jun 14; 111(23):3105-11. PubMed ID: 15939821
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience.
    Ruiz MJ, Escribano P, Delgado JF, Jiménez C, Tello R, Gómez MA, de la Calzada CS.
    J Heart Lung Transplant; 2006 Nov 14; 25(11):1353-7. PubMed ID: 17097500
    [Abstract] [Full Text] [Related]

  • 11. [A case of mixed connective tissue disease with lupus-like manifestations of the central nervous system, successfully treated with cyclophosphamide combined with prednisolone].
    Kuroki M, Okayama A, Kuwata G, Okamoto M, Tanaka G, Iga M, Kai Y, Matsuyama M, Murai K, Tsubouchi H.
    Ryumachi; 2000 Jun 14; 40(3):627-32. PubMed ID: 10920688
    [Abstract] [Full Text] [Related]

  • 12. Lupus-associated pulmonary hypertension: long-term response to vasoactive therapy.
    Heresi GA, Minai OA.
    Respir Med; 2007 Oct 14; 101(10):2099-107. PubMed ID: 17618103
    [Abstract] [Full Text] [Related]

  • 13. Ten year survival of a patient with advanced pulmonary hypertension and mixed connective tissue disease treated with immunosuppressive therapy.
    Dahl M, Chalmers A, Wade J, Calverley D, Munt B.
    J Rheumatol; 1992 Nov 14; 19(11):1807-9. PubMed ID: 1491407
    [Abstract] [Full Text] [Related]

  • 14. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
    Singh TP, Rohit M, Grover A, Malhotra S, Vijayvergiya R.
    Am Heart J; 2006 Apr 14; 151(4):851.e1-5. PubMed ID: 16569546
    [Abstract] [Full Text] [Related]

  • 15. Sildenafil for pulmonary arterial hypertension associated with connective tissue disease.
    Badesch DB, Hill NS, Burgess G, Rubin LJ, Barst RJ, Galiè N, Simonneau G, SUPER Study Group.
    J Rheumatol; 2007 Dec 14; 34(12):2417-22. PubMed ID: 17985403
    [Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM, Jabbour A, Weintraub R, Brown K, Hayward CS, Macdonald PS.
    J Heart Lung Transplant; 2007 Nov 14; 26(11):1079-83. PubMed ID: 18022071
    [Abstract] [Full Text] [Related]

  • 17. Comparison of baseline characteristics and survival between patients with idiopathic and connective tissue disease-related pulmonary arterial hypertension.
    Ruiz-Cano MJ, Escribano P, Alonso R, Delgado J, Carreira P, Velazquez T, Sanchez MA, Sáenz de la Calzada C.
    J Heart Lung Transplant; 2009 Jun 14; 28(6):621-7. PubMed ID: 19481024
    [Abstract] [Full Text] [Related]

  • 18. The frequency of anti-beta2-glycoprotein I antibodies is low and these antibodies are associated with pulmonary hypertension in mixed connective tissue disease.
    Hasegawa EM, Caleiro MT, Fuller R, Carvalho JF.
    Lupus; 2009 Jun 14; 18(7):618-21. PubMed ID: 19433462
    [Abstract] [Full Text] [Related]

  • 19. [Two years of multidisciplinary diagnostic and therapeutic experience in patients with pulmonary arterial hypertension].
    Tokgözoğlu L, Akdoğan A, Okutucu S, Kaya EB, Aytemir K, Ozkutlu H.
    Turk Kardiyol Dern Ars; 2009 Sep 14; 37(6):378-83. PubMed ID: 20019450
    [Abstract] [Full Text] [Related]

  • 20. Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
    Reesink HJ, van der Plas MN, Verhey NE, van Steenwijk RP, Kloek JJ, Bresser P.
    J Thorac Cardiovasc Surg; 2007 Feb 14; 133(2):510-6. PubMed ID: 17258590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.